Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
robert.massey@ndm.ox.ac.uk

Robert Massey

Recent publications

BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study

Massey RJ. et al, (2024), Cardiovascular Diabetology, 23

BMI Variability and Cardiovascular Outcomes Within Clinical Trial and Real-World Environments in Type 2 Diabetes: An IMI2 SOPHIA study

Massey RJ. et al, (2024)

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

Tobias DK. et al, (2023), Nature Medicine, 29, 2438 - 2457

Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review.

Young KG. et al, (2023), Communications medicine, 3

Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors

Young KG. et al, (2023)

More publications